A suite of new studies links popular weight-loss and diabetes drugs to lower cancer risks and better outcomes for those with the disease, though researchers say more research is needed

4 days ago 4
A suite of caller studies suggest drugs specified arsenic Ozempic and Zepbound mightiness dilatory tumor progression and amended survival, but much probe is needed to corroborate the findings.
Read Entire Article